STAMFORD, Conn. and HOUSTON, June 2, 2026 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve and a leading provider of...
Business Activity Index at 52.6%; New Orders Index at 50.3%; Employment Index at 46.4%; Supplier Deliveries Index at 51%
TEMPE, Ariz., Aug. 5, 2025 /PRNewswire/ --...
Endocarditis, a heart infection caused by bacteria in the bloodstream, is experiencing growing incidence due to rising healthcare-associated infections, intravenous drug use, and aging populations with prosthetic valves. Advances in diagnostic imaging, AI-assisted echocardiography, and minimally invasive cardiac procedures are improving detection and patient outcomes. However, challenges like early detection difficulties and antimicrobial resistance persist. North America leads in the endocarditis market, with significant growth seen in the Asia-Pacific due to increased cardiovascular cases and healthcare investments. Key players like Pfizer and Teva Pharmaceutical are driving innovations in the sector.
Endocarditis, a heart infection caused by bacteria in the bloodstream, is experiencing growing incidence due to rising healthcare-associated infections, intravenous drug use, and aging populations with prosthetic valves. Advances in diagnostic imaging, AI-assisted echocardiography, and minimally invasive cardiac procedures are improving detection and patient outcomes. However, challenges like early detection difficulties and antimicrobial resistance persist. North America leads in the endocarditis market, with significant growth seen in the Asia-Pacific due to increased cardiovascular cases and healthcare investments. Key players like Pfizer and Teva Pharmaceutical are driving innovations in the sector.
Jewellok is a specialty gas automatic changeover manifold manufacturer and supplier, manufacturing semi-automatic and automatic stainless steel high-purity oxygen, nitrogen, helium, and argon gas...
ATLANTA, July 30, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) announced that its Board of Directors has declared a quarterly dividend of $0.067 per share, payable on or about August 21, 2025, to stockholders of record as of the close of business on August 12, 2025.
ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it...
Key Takeaways
The Standard® Turbocharger program features complete, all-new, no-core Turbocharger Kits for gas and diesel vehiclesStandard® Turbocharger Kits include all of the related parts...
ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its third quarter ended June 30, 2025, after U.S. markets close on Monday, August 4, 2025. On Tuesday, August 5, 2025, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call.
This release explores how Pacuzzi’s 2025 cookware model delivers on the rising need for modular, space-saving tools that support healthier cooking and efficient kitchens.
This release explores how Pacuzzi’s 2025 cookware model delivers on the rising need for modular, space-saving tools that support healthier cooking and efficient kitchens.